YLZ(SZ:300096)2021-04-28 16:00Financial Performance - The company's operating revenue for Q1 2021 was ¥72,362,291.17, a decrease of 20.61% compared to ¥91,146,123.32 in the same period last year[7]. - The net profit attributable to shareholders was -¥56,743,247.14, representing a decline of 14.47% from -¥49,571,851.16 year-on-year[7]. - The net cash flow from operating activities was -¥161,036,894.15, which is 11.27% worse than -¥144,730,098.23 in the previous year[7]. - The basic and diluted earnings per share were both -¥0.13, a decrease of 14.48% compared to -¥0.12 in the same period last year[7]. - The weighted average return on net assets was -8.28%, down from -7.14% year-on-year, indicating a decline of 1.14%[7]. - The net profit for the first quarter of 2021 was -19,314,661.88 CNY, compared to -28,845,379.06 CNY in the same period last year, showing an improvement of approximately 33.5%[53]. - The total comprehensive income for the first quarter was -26,725,333.73 CNY, compared to -28,845,379.06 CNY in the previous year, indicating a reduction in losses[54]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,831,066,954.77, down 0.90% from ¥1,847,676,328.41 at the end of the previous year[7]. - The net assets attributable to shareholders decreased by 8.94% to ¥653,500,596.72 from ¥717,654,515.71 at the end of the previous year[7]. - Total liabilities rose to CNY 1,004,010,873.25 from CNY 940,001,341.70, reflecting an increase of approximately 6.8%[41]. - The company's equity attributable to shareholders decreased to CNY 653,500,596.72 from CNY 717,654,515.71, a decline of about 8.9%[42]. - Current assets totaled CNY 1,125,163,932.35, down from CNY 1,154,556,923.40, indicating a decrease of about 2.6%[40]. - Total liabilities increased to CNY 996,905,585.00 from CNY 896,389,255.08[48]. - Total equity decreased to CNY 521,226,271.42 from CNY 547,951,605.15[48]. Cash Flow - Cash inflow from operating activities was 178,750,376.59 CNY, slightly up from 172,731,279.84 CNY year-on-year[57]. - The cash flow from financing activities generated a net inflow of 55,319,105.56 CNY, compared to a net outflow of -55,994,433.53 CNY in the same period last year[58]. - The net cash flow from investment activities was 23,578,843.86 CNY, a significant improvement compared to -4,952,820.97 CNY in the previous year[61]. - Cash and cash equivalents at the end of the period stood at 346,034,923.73 CNY, compared to 245,188,980.62 CNY at the end of the same period last year, reflecting an increase of approximately 41%[58]. Operational Highlights - The company received government subsidies amounting to ¥4,665,996.55 during the reporting period[8]. - The company has secured new medical insurance information platform projects in multiple provinces, enhancing its core competitiveness in the field[21]. - The company is actively developing new products and technologies, including smart hospitals and regulatory monitoring platforms[21]. - The company faces operational risks due to the expansion of its product and service categories, necessitating a robust customer service system[24]. - The company is actively developing high-tech products characterized by new infrastructure technologies such as AI, 5G, IoT, and blockchain, aiming to transition to a digital ecosystem operation model[30]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,197[10]. - The largest shareholder, Zhang Xi, holds 16.21% of the shares, with 69,681,649 shares, of which 52,261,237 are pledged[10]. Strategic Initiatives - The company plans to issue up to 129 million A-shares, raising a total of no more than 829.47 million yuan, which will be used to repay bank loans and supplement working capital[28]. - The company has approved the transfer of 52% equity in its subsidiary, Xiamen Yilianzhong Yifang Technology Co., Ltd., for 12.49 million yuan to optimize resource allocation and enhance operational capacity[28]. - The company emphasizes the importance of talent retention and has implemented attractive compensation mechanisms and career development plans to stabilize its core talent team[30]. - The company has engaged in discussions with institutional investors regarding its healthcare and public service business strategies[34]. Compliance and Governance - The company has not reported any violations regarding external guarantees during the reporting period[32]. - The company has not experienced any non-operational fund occupation by its controlling shareholders or related parties during the reporting period[33]. - The first quarter report has not been audited, indicating that the figures may be subject to change[70].